Ovarian hyperstimulation syndrome following surgical removal of a complete hydatidiform mole: a case report. [PDF]
J Med Case Rep, 2019 Background Generally, ovarian hyperstimulation syndrome develops after superovulation caused by ovulation-inducing drugs in infertile patients. However, ovarian hyperstimulation syndrome associated with natural pregnancy is rare, and most cases of ...
Tsubokura H +4 more
europepmc +3 more sources
Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance. [PDF]
Am J Surg Pathol, 2022 Combined p57 immunohistochemistry and DNA genotyping refines classification of products of conception specimens into specific types of hydatidiform moles and various nonmolar entities that can simulate them.
Xing D, Miller K, Beierl K, Ronnett BM.
europepmc +2 more sources
Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles. [PDF]
Int J Gynecol Pathol, 2022 Complete hydatidiform mole (CHM) is a premalignant proliferative disease of the placenta characterized by misexpression of imprinted gene products, most notably p57.
Murphy KM +6 more
europepmc +2 more sources
Methylation profiles of imprinted genes are distinct between mature ovarian teratoma, complete hydatidiform mole, and extragonadal mature teratoma. [PDF]
Mod Pathol, 2021 Mature ovarian teratoma is considered to be a parthenogenetic tumor that arises from a single oocyte/ovum. Conversely, complete hydatidiform mole (CHM) is androgenetic in origin: classic CHM arises from a single or two sperm.
Kato N, Kamataki A, Kurotaki H.
europepmc +2 more sources
Recurrent Thyroid Storm Caused by a Complete Hydatidiform Mole in a Perimenopausal Woman. [PDF]
Case Rep Endocrinol, 2020 Background Gestational trophoblastic disease (GTD) which includes hydatidiform mole, invasive mole, placental site trophoblastic tumor, and choriocarcinoma is a rare cause of hyperthyroidism due to excess production of placental human chorionic ...
Jayasuriya A +3 more
europepmc +2 more sources
Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole. [PDF]
Clinics (Sao Paulo), 2020 OBJECTIVES: This study aimed to evaluate the potential relationship between oxidative stress, dietary intake, and serum levels of antioxidants in patients with a complete hydatidiform mole (CHM) compared with controls.
Ferraz L +7 more
europepmc +2 more sources
A case report of twin pregnancy with complete hydatidiform mole following two frozen-embryos subsequent to ICSI (Intracytoplasmic Sperm Injection) [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2022 Introduction: Intracytoplasmic sperm injection (ICSI) is an assisted reproductive technique for entering a sperm into the oocyte. In this study, a case of complete molar pregnancy which occurred following two frozen- embryo subsequent to ICSI was ...
Morvarid Irani +3 more
doaj +1 more source
The expression of Ki-67 marker in the hydatidiform mole [PDF]
The Moldovan Medical Journal, 2022 Background: The hydatiform mole is charcaterized by a pathological proliferation of the trophoblast. Its evaluation could predict the progression to gestational trophoblastic neoplasia.
Ecaterina Carpenco +4 more
doaj +1 more source
Journal of Maternal-Fetal & Neonatal Medicine, 2023 Introduction A twin pregnancy involving a hydatidiform mole (HM) coexisting with a developing fetus is an extremely rare obstetric complication, which typically presents as a complete hydatidiform mole with a coexisting fetus (CHMCF) or a partial ...
Guan Wang, Hongyan Cui, Xu Chen
semanticscholar +1 more source
Diagnostics, 2023 Twin pregnancy with a complete hydatidiform mole and coexisting fetus (CHMCF) is an exceedingly rare condition with an incidence of about 1 in 20,000–100,000 pregnancies.
Hera Jung
semanticscholar +1 more source